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The case of 38-month-old boy is being reported who was brought to the pediatrics clinic with fever, cough, hemoptysis, and
breathingdifficulty.Imagingstudiesrevealed arightlowerchestmass.Lobectomyandhistopathological examinationrevealed itto
be predominantly solid pleuropulmonary blastoma type II. It is a rare pediatric pleuropulmonary tumor with aggressive behavior
and tendency to spread to the brain. The case is being presented to make the general histopathologist aware of this rare entity and
to highlight to the pediatric physicians/surgeons, radiologists, and histopathologists the fact that lung cysts in infants and young
children should be evaluated seriously and sampled thoroughly to diagnose cases of type I pleuropulmonary blastoma which will
progress over time to type II or type III tumors. Also the siblings and first degree relatives of the patient should be screened for
associated pulmonary and extrapulmonary benign and malignant conditions.
1. Introduction
Pleuropulmonaryblastoma(PPB)isarare,aggressive,dyson-
togenetic, and malignant tumor of intrathoracic (pulmonary,
pleural,orcombined)mesenchyme[1,2].Itwasfirstreported
in a study of 11 patients by Manivel et al. in 1988 [3]. PPB
affects infants and children under four years of age [4].
Morphologically, PPB has three types (I, II, and III) and a
fourth type (Ir) was added in 2006 [5].
Th i sc a s ei sb e i n gr e p o r t e dw i t ha na i mt oi n c r e a s et h e
general awareness for this entity so as to recognize this rare
entityearlyinitscourse,sincetypeItumors(resemblingcon-
g e n i t a ll u n gcy s t )c a np r o g r e s so v e rt i m et oa g g r e s s i v et y p eI I
and type III tumors. Therefore, early histological recognition
and differentiation from congenital airway malformations
and other benign cysts are very important.
2. Case Presentation
A 38-month-old boy was brought to the pediatrics clinic
with fever, cough, hemoptysis, and breathing difficulty. His
chest radiograph and computerized tomography (CT) scan
(Figure 1) showed a right lung lower lobe heterogeneous
mass (3.9 × 3.3 × 3.2cm) and right middle lobe atelectasis
without pleural effusion. CT guided biopsy was performed
and a single biopsy core was obtained. It was composed
entirely of hyaline cartilage; the chondrocytes were increased
i nn u m b e ra n ds h o w e dm i l dn u c l e a rp l e o m o r p h i s m ,n o
admixtureofsofttissue,inflammation,ornecrosis.Therefore,
a differential diagnosis of chondroma, chondroid hamar-
toma, and pleuropulmonary blastoma was raised and lobec-
tomy was suggested. Right thoracotomy was performed;
the mass was found to be limited to the right lower lobe
without involvement of the pleura. Right lower lobectomy
was performed without complications. The excised mass
was solid, circumscribed, firm, and gray-white measuring
4.2 × 3.2 × 3cm surrounded by congested and partly
solidified lung tissue. Its cut surface was heterogeneously
gray-white with focal areas of hemorrhages and cartilagi-
nous tissue (Figure 2). Microscopically, it was composed of
many lobules of hyaline cartilage (Figure 3)i nw h i c ht h e
constituent chondrocytes varied from bland to moderately
pleomorphic (Figure 4) with areas of necrosis (10%). The
interveningstromavariedfromblastema-liketofibromyxoid
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Figure 1: CT chest: right lung lower lobe peripheral mass.
Figure 2: Circumscribed solid tumor mass surrounded by lung
tissue.
Figure 3: Islands of mature and immature hyaline cartilage. H&E:
×100.
t od e n s es p i n d l ec e l lt y p e( Figure 5), harboring an occasional
microscopic cyst lined by ciliated cuboidal to columnar cells
with subepithelial condensation of blastema-like to spindle
shaped neoplastic cells (Figure 6). There were focal areas of
skeletal muscle differentiation, bizarre multinucleate giant
cells, and many scattered mitoses throughout (Figures 7
and 8). The surrounding pulmonary tissue showed areas of
Figure 4: Interface of chondrosarcoma and rhabdomyosarcoma.
H&E: ×200.
Figure 5: Nodules of blastema-like cells separated by loose tissue.
H&E: ×100.
Figure 6: Ciliated columnar epithelium lining the microcyst and
underlying condensation of small round cells. H&E: ×200.
hemorrhages and atelectasis; the tumor was abutting but not
involving the pleura. A small peribronchial lymph node did
not show any tumor infiltration. Immunohistochemically,
t h er h a b d o m y o b l a s t sw e r ep o s i t i v ef o rD e s m i na n dm u s c l e
specific actin (MSA) (Figures 9 and 10). The chondrocyte
nuclei were positive for S100 (Figure 11) and the epithelium
lining the cysts was positive for CK19 (Figure 12). In view
of a predominantly solid pattern with scattered occasional
microcysts, a diagnosis of pleuropulmonary blastoma type
III was made and the material was sent to The InternationalCase Reports in Pathology 3
Figure 7: Anaplastic large bizarre cells amidst malignant pleomor-
phic cells. H&E: ×200.
Figure 8: Scattered ovoid eosinophilic rhabdomyoblasts. H&E:
×200.
Figure 9: Desmin: cytoplasmic staining: ×400.
Figure 10: MSA: cytoplasmic staining: ×200.
Figure 11: S100: nuclear staining in cartilage tissue: ×200.
Figure 12: CK19 cytoplasmic staining of cyst lining epithelial cells:
×200.
Pleuropulmonary Blastoma Registry, Minnesota, USA, for
confirmation.Thereitwasconfirmedtobepleuropulmonary
blastoma and retyped as predominantly solid type II tumor
( d u et ot h ep r e s e n c eo fm i c r o c y s t s ) .Th ep a r e n t so ft h ec h i l d
were informed and the treatment options were discussed;
however, they refused any further treatment as the child had
apparentlyimprovedsymptomaticallyandwantedmoretime
todecide.Threemonthslaterthepatientwasbroughtbackto
the oncology clinic with complaints of headache, vomiting,
and dizziness. CT and magnetic resonance imaging (MRI)
of the brain showed an intra-axial right frontal lobe mass
measuring7.3×4.2×4cm(notapparentinthebrainCTdone
three months earlier) with central area of necrosis causing
compression of the ipsilateral lateral ventricle and significant
midlineshift(Figure 13). Craniotomy was performed and the
resectedmasswasreceivedinthelaboratoryasmultiplefrag-
ments collectively measuring 7 × 5 × 1cm. Microscopically,
the tumor was composed of dense spindle cell proliferation
with areas of hemorrhages, necrosis, and scattered anaplastic
bizarre giant cells (Figure 14). The tumor cells were positive
for Desmin and MSA (Figure 15).Thepatientleftthehospital
in a conscious and ambulatory state awaiting chemotherapy
but was readmitted after a week with massive intracranial
hemorrhage(rightfrontallobe)andbreathedhislastaftertwo
days of hospitalization.4 Case Reports in Pathology
Figure 13: MRI brain: large right frontal lobe mass.
Figure14:Metastaticsarcomaandedematousbraintissueinterface.
H&E: ×200.
Figure 15: Brain metastasis, Desmin cytoplasmic staining: ×400.
3. Discussion
Pleuropulmonary blastoma is a rare intrathoracic tumor
accounting for 15% of all primary pediatric pulmonary
tumors and 25% of these cases occur in familial settings [4];
the associated malignancies in first- and second-degree rel-
atives include rhabdomyosarcomas, synovial sarcoma, pleu-
ropulmonary blastoma, thyroid carcinomas, ovarian Sertoli-
Leydig cell tumors, gonadal germ cell tumors, and certain
types of leukemia [2, 4, 6, 7]. Associated benign conditions
include thyroid nodule, cystic nephroma, colonic polyps,
benign eye and nasal tumors, and neurofibromatosis [4–7].
The age of presentation is usually less than 4 years; very few
c a s e sh a v eb e e nr e p o r t e di np a t i e n t so v e r1 0y e a r so fa g ea n d
only one case has been reported at 36 years [4]. The median
age of presentation depends largely on the tumor type. For
t y p eIt u m o r s ,t h em e d i a na g ei s1 0m o n t h s ;f o rt y p eI r ,t h e
median age is 48 months; for type II, the median age is 34
months; and for type III, the median age is 44 months [5].
There is no gender predilection and the tumor occurs more
commonlyontherightside[1].Certaingeneticmutationsare
associated with pleuropulmonary blastomas; these include
germ line DICER1 mutation (loss of function) in familial
cases, gains of chromosome 8 (most consistent chromosomal
abnormality), trisomy 2, unbalanced translocation between
chromosomes 1 and X, and p53 mutations or deletions [2].
Clinically, the patient may present with chest or upper
abdominalpain,fever,dyspnea,cough,hemoptysis,anorexia,
malaise, or neurological symptoms resulting from brains
metastasis [1]. Imaging studies have shown varied appear-
ances depending on the tumor type; these include unilocular
cysts, a multicystic structure, a cyst containing a polypoid
mass,andsolid-cysticorentirelysolidmassesofvariablesizes
located peripherally in the lung with or without involvement
of the pleura or chest wall and may fill the entire hemithorax
[1,5].Theentirethoraxshouldbescrutinizedforthepresence
of any asymptomatic cysts which could be forerunner of type
It u m o r s[ 5].
Fine needle aspiration cytology of the primary tumors
is usually not helpful in reaching a diagnosis. Image guided
biopsies when planned should yield multiple needled cores
keeping in view the characteristic morphological diversity
of the tumor. A solitary needle biopsy core may sample a
single tissue type with relatively bland nuclear features or
m a ys a m p l et h ep o r t i o no fc y s tw a l lt h a th a sd i s c o n t i n u o u s
subepithelial condensation of cells (a diagnostic feature of
PPB type I), hence concealing the true nature of the disease,
as occurred in this case. Therefore, tumor resection and
histological examination should be undertaken as a standard
procedure to reach a confident definitive diagnosis on which
appropriate aggressive therapy will be based [1, 5].
Three types of the PPB have been described based
on morphology. Type I tumors carry the most favorable
prognosis and account for 15% to 20% of all PPB, whereas
type II and type III tumors behave aggressively and together
(distributedequally)accountfor80%to85%ofallPPB.These
three tumor types form a continuum with progression over
t i m ef r o mt y p eIt ot y p eI I It u m o r[ 4].
Type I tumors are purely cystic, peripherally located,
show striking absence of chest wall invasion, and may be
single or multicystic and the cyst wall is usually thin without
grossly visible solid areas [6]. On microscopic examination,
the cysts may be round- to oval-compressed and lined by
cuboidal or columnar ciliated epithelium; the subepitheliumCase Reports in Pathology 5
maycontainacontinuousordiscontinuousbutcharacteristic
layer of primitive round- to spindle-shaped cells reminiscent
of cambium layer of sarcoma botryoides with scattered few
rhabdomyoblasts. The primitive cell condensations in the
subepithelium may be so scanty and focal that thorough
sampling of the cyst wall may be required to locate them;
moreover, finding of nodules of immature cartilage should
raise suspicion of PPB and merit thorough sampling of the
specimen. The differential diagnosis for PPB type I includes
congenital pulmonary airway malformation (CPAM) and
fetal lung interstitial tumor (FLIT). CPAM is a benign
cyst without subepithelial malignant cell condensations or
immature cartilage. FLIT is a newly recognized entity with
some overlap with type I pleuropulmonary blastoma and is
characterized by irregular airspaces enclosed by irregularly
thickened septae composed of immature mesenchyme and
lined by polygonal cells with underlying thin smooth muscle
layer without cambium layer of blastema-like cells [1, 5–7].
Type Ir (type I-regressed) tumors are cystic containing
few spindle shaped cells in the cyst wall with few foci of
dystrophic calcification but without subepithelial malignant
cell condensation. It might represent a regressed or a genet-
ically destined but abortive type I tumor. Only 8% of such
tumors show onward progression to PPB type II or type III.
Its differential diagnosis is the same as for type I tumors [5].
TypeIItumorsarepartlysolidandpartlycystic,therefore
s h a r i n gf e a t u r e so fb o t ht y p eIa n dt y p eI I It u m o r s .Th ec y s t s
m a ybevi si b legr os s l yo rmicr osco p icall y;ifth ecys tsa r eseen
only microscopically the tumors are called predominantly
solid type II tumors, but if the tumor is largely cystic it is
called predominantly cystic type II tumor. Microscopically
these cysts are identical to the cysts of type I tumors, whereas
the solid portions show microscopic features identical to
type III tumors. Predominantly cystic type II tumors are to
be differentiated from type I tumors; the aforesaid tumors
have plaque-like or nodular proliferation in the cyst wall
composed of blastema-like cells or malignant spindle cells
withorwithoutrhabdomyoblastsinthesubepithelium[4–7].
Type III tumors are entirely solid tumors usually pre-
senting as large, well-circumscribed masses partly filling the
hemithorax with or without attachment to the chest wall or
mediastinum. The tumor may be friable due to hemorrhages
and necrosis. Microscopically, there are blastematous foci in
which the constituent cells have scanty cytoplasm, round
to ovoid nuclei with granular chromatin, inconspicuous
nucleoli, and frequent mitoses; their stroma is less dense
and fibroblastic that blends with sarcomatous component.
The sarcomatous component is composed of spindle cell
proliferationarrangedinfascicularpattern;theirnucleishow
anisonucleosis and hyperchromasia with scattered pleomor-
phic bizarre giant cells. Such anaplastic bizarre cells are a
f e a t u r eo ft y p eI I Ia n ds o m et y p eI It u m o r s ,b u tt h e ya r e
not found in type I tumors. There are scattered polygonal or
elongated rhabdomyoblasts (some having cytoplasmic cross-
striations) occurring singly or in clusters and sheets. Also,
there is a variable proportion of immature to mature hyaline
cartilage; the cartilage component may be small or large in
amount and the chondrocytes may show a degree of cellu-
larity and pleomorphism to the extent of chondrosarcoma.
There may be areas of infarction and necrosis affecting the
cartilaginous, blastematous, or sarcomatous component pro-
ducing pseudocysts (not lined by epithelial cells); similarly,
therecanbefociofmyxoiddegeneration.Duetothepresence
of the malignant spindle cell component, the differential
diagnosis for type II and type III tumors includes primary or
secondaryrhabdomyosarcoma,malignantteratoma,synovial
sarcoma, other spindle cell/undifferentiated sarcomas, or
pulmonary blastoma, whereas due to the presence of prim-
itive blastema, the differential diagnosis includes metastatic
Wilm’s tumor. Location, morphology, imaging studies, and
immunohistochemistry are helpful in making this differen-
tiation [4–7].
Immunohistochemical staining is not essential for diag-
nosis but is supportive of the morphological diagnosis.
Desmin and muscle specific actin are usually positive in
t h eo b v i o u sr h a b d o m y o b l a s t sa n da l s oi nf e ws m a l lc e l l so f
cambium layer (subepithelial condensation). The blastema
cells are weakly positive for muscle specific actin and neuron
specific enolase but are negative for WT1. The mature and
immature chondrocyte nuclei stain for S100. Cytokeratin
stains epithelial cells lining the cysts. Vimentin stains rhab-
domyoblasts, chondrocytes, and other foci of sarcomatous
proliferation. Proliferation markers like Ki67 show high level
of positivity in all cell types [1, 4, 5].
The commonest site for metastatic spread is the brain
[4]. The metastatic deposits are characterized by simplified
histologicalappearancesascomparedtothediversemorphol-
ogy of the primary tumor. These metastases are composed
of either rhabdomyosarcoma or undifferentiated spindle cell
sarcoma without cysts or cartilaginous component. There-
fore, it is mandatory to follow up these patients by brain
imagingstudies[4].Thelongtermsurvivalofmorethan80%
has been reported for type I and less than 50% for type II and
III tumors [4] .T y p eIt u m o r sp r o g r e s so v e rt i m et ot y p eI I
and type III tumors [4, 5, 7].
The recommended treatment for type I tumors consists
of surgical excision and adjuvant chemotherapy. For type
Ir tumors only follow-up but no chemotherapy is recom-
mended. For the usual type II and type III tumors, the
treatment consists of aggressive surgery and chemotherapy.
ForlargetypeIIandtypeIIItumors,afterinitialconfirmation
bymultipleneedlecorebiopsies,2to4coursesofneoadjuvant
chemotherapy are instituted reducing the tumor size usually
by more than 90%, followed by surgical resection. The
recommended chemotherapeutic agents are ifosfamide, vin-
cristine, actinomycin D, and doxorubicin (IVADo regimen).
Forbrain metastasis,the recommendedtreatmentconsists of
all three modalities, that is, surgery, radiation therapy, and
chemotherapy in an attempt to achieve cure [5, 7].
For recurrent tumors high dose consolidation therapy
(HDCT) with autologous stem cell rescue (ASCR) is rec-
ommended. Studies have shown that there is no addi-
tive advantage of radiation therapy following surgery and
chemotherapy. Therefore, radiation therapy is reserved for
patientswithknownbutnonresectabletumorsorforresidual
tumors after chemotherapy [5].
In summary, the clinicians and pathologists should have
a high index of suspicion for lung cysts that present in6 Case Reports in Pathology
pediatric age. Also the patients, their siblings, and their first
degreerelativesshouldbescreenedforassociatedbenignand
malignant conditions.
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